Camurus AB (CAMRF)
61.75
0.00 (0.00%)
USD |
OTCM |
Oct 29, 16:00
Camurus Price : 61.75 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 28, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 27, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 26, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 29.00 |
| Oct 23, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 22, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 21, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 20, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 19, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 16, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 15, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 14, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 13, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 17.00 |
| Oct 12, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 09, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 08, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 07, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 06, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 05, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 02, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Oct 01, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Sep 30, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 16.00 |
| Sep 29, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 0.000 |
| Sep 28, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 30.00 |
| Sep 25, 2026 | 61.75 | 61.75 | 61.75 | 61.75 | 75.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Swedencare AB | 2.30 |
| Moberg Pharma AB | 1.00 |
| Infant Bacterial Therapeutics AB | 6.85 |
| AstraZeneca PLC | 174.40 |
| ANI Pharmaceuticals, Inc. | 73.16 |
Price Related Metrics
| PE Ratio | 51.10 |
| PS Ratio | 15.29 |
| PEG Ratio | 13.88 |
| Price to Book Value | 7.599 |
| Price to Free Cash Flow | 52.27 |
| Earnings Yield | 1.96% |
| Market Cap | 3.675B |
| PEGY Ratio | 13.88 |
| Operating PE Ratio | 41.43 |
| Normalized PE Ratio | 51.10 |